Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioNano Genomics Inc (BNGO)
NASDAQ:BNGO
BioNano Genomics (BNGO) Stock Price & Analysis
8,835 Followers
BNGO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.52 - $6.59
Previous Close$0.66
Volume1.36M
Average Volume (3M)1.43M
Market Cap
$53.27M
Enterprise Value$65.98M
Total Cash (Recent Filing)$66.70M
Total Debt (Recent Filing)$79.41M
Price to Earnings (P/E)―
Beta3.31
Next Earnings
Aug 08, 2024EPS Estimate
-$0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.01
Shares Outstanding66,856,804
10 Day Avg. Volume1,070,386
30 Day Avg. Volume1,431,632
Standard Deviation0.80
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.81
Price to Sales (P/S)1.39
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.83
Enterprise Value/Gross Profit6.90
Enterprise Value/Ebitda-0.31
Forecast
1Y Price Target
$4.93Price Target Upside641.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
BioNano Genomics News
Bulls Say, Bears Say
Bulls Say
Healthcare Coding UpdateBNGO expects an update from the American Medical Association regarding a Category 1 CPT code, which could be a key catalyst for the company.
Product Launch & Financial PerformanceBionano rolls out the Stratys, delivers a Q1 revenue beat and maintains its full year 2024 revenue guidance.
Scientific PublicationsBNGO announced it achieved a record number of 97 publications in Q1, up 83% year over year.
Bears Say
Financial StrategyThe company may need to leverage its ATM, adding substantial dilution given the low share price.
Sales StrategyBNGO reduced its direct sales reps by 50%, leading to concerns about its ability to drive a large number of OGM placements.
Stock PerformanceBNGO shares have declined by approximately 50% to $1.30, well below the conversion price of $2.86.
---
Ownership Overview
7.51% Insiders
2.83% Mutual Funds
2.70% Other Institutional Investors
86.96% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BNGO FAQ
What was BioNano Genomics Inc’s price range in the past 12 months?
BioNano Genomics Inc lowest stock price was $0.52 and its highest was $6.59 in the past 12 months.
What is BioNano Genomics Inc’s market cap?
Currently, no data Available
When is BioNano Genomics Inc’s upcoming earnings report date?
BioNano Genomics Inc’s upcoming earnings report date is Aug 08, 2024 which is in 21 days.
How were BioNano Genomics Inc’s earnings last quarter?
BioNano Genomics Inc released its earnings results on May 08, 2024. The company reported -$0.6 earnings per share for the quarter, beating the consensus estimate of -$0.644 by $0.044.
Is BioNano Genomics Inc overvalued?
According to Wall Street analysts BioNano Genomics Inc’s price is currently Undervalued.
Does BioNano Genomics Inc pay dividends?
BioNano Genomics Inc does not currently pay dividends.
What is BioNano Genomics Inc’s EPS estimate?
BioNano Genomics Inc’s EPS estimate is -$0.42.
How many shares outstanding does BioNano Genomics Inc have?
BioNano Genomics Inc has 80,806,800 shares outstanding.
What happened to BioNano Genomics Inc’s price movement after its last earnings report?
BioNano Genomics Inc reported an EPS of -$0.6 in its last earnings report, beating expectations of -$0.644. Following the earnings report the stock price went up 6.522%.
Which hedge fund is a major shareholder of BioNano Genomics Inc?
Among the largest hedge funds holding BioNano Genomics Inc’s share is GMT Capital Corp. It holds BioNano Genomics Inc’s shares valued at N/A.
---
BioNano Genomics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.93 (641.91% Upside)
$4.93 (641.91% Upside)
Blogger Sentiment
Bearish
BNGO Sentiment 67%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 530.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-89.83%
12-Months-Change
Fundamentals
Return on Equity
-144.33%
Trailing 12-Months
Asset Growth
-45.92%
Trailing 12-Months
Company Description
BioNano Genomics Inc
BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.
---
BNGO Earnings Call
Q1 2024
0:00 / 0:00
---
BNGO Stock 12 Month Forecast
Average Price Target
$4.93
▲(641.91% Upside)
Technical Analysis
Best Analysts Covering BNGO
1 Year
1 Year Success Rate
0/9 ratings generated profit
1 Year Average Return
-59.40%
reiterated a buy rating 2 months ago
Copying Jeffrey Cohen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -59.40% per trade.
---